Michel Detheux
2020
In 2020, Michel Detheux earned a total compensation of $16.8M as Ph.D. Chief Executive Officer at iTeos Therapeutics, a 964% increase compared to previous year.
Compensation breakdown
| Bonus | $121,250 |
|---|---|
| Non-Equity Incentive Plan | $242,500 |
| Option Awards | $15,982,781 |
| Salary | $462,500 |
| Other | $7,500 |
| Total | $16,816,531 |
Detheux received $16M in option awards, accounting for 95% of the total pay in 2020.
Detheux also received $121.3K in bonus, $242.5K in non-equity incentive plan, $462.5K in salary and $7.5K in other compensation.
Rankings
In 2020, Michel Detheux's compensation ranked 317th out of 13,090 executives tracked by ExecPay. In other words, Detheux earned more than 97.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 317 out of 13,090 | 98th |
Division Manufacturing | 106 out of 5,620 | 98th |
Major group Chemicals And Allied Products | 36 out of 2,253 | 98th |
Industry group Drugs | 32 out of 1,953 | 98th |
Industry Biological Products, Except Diagnostic Substances | 10 out of 411 | 98th |
Source: SEC filing on May 5, 2021.
Detheux's colleagues
We found two more compensation records of executives who worked with Michel Detheux at iTeos Therapeutics in 2020.
News
iTeos Therapeutics CEO Michel Detheux's 2023 pay falls 45% to $5.8M
April 25, 2024
iTeos Therapeutics CEO Michel Detheux's 2022 pay jumps 88% to $11M
April 27, 2023
iTeos Therapeutics CEO Michel Detheux's 2021 pay falls 67% to $5.6M
April 25, 2022
iTeos Therapeutics CEO Michel Detheux's 2020 pay jumps 964% to $17M
May 5, 2021